CollPlant Biotechnologies (CLGN) Long-Term Investments (2022 - 2025)
CollPlant Biotechnologies (CLGN) reported Long-Term Investments of $76000.0 for Q4 2025, down 35.59% on a YoY basis from $118000.0 in Q4 2024, and down 35.59% quarter-over-quarter from $118000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Long-Term Investments (2022 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Long-Term Investments for 4 years, with the latest figure at $76000.0 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments fell 35.59% year-over-year to $76000.0; the trailing twelve-month figure through Dec 2025 stood at $76000.0 (down 35.59% YoY), and the FY2025 full-year result was $76000.0, down 35.59% from the prior year.
- Long-Term Investments for Q4 2025 stood at $76000.0, down from $118000.0 in the prior quarter.
- The five-year high for Long-Term Investments was $188000.0 in Q4 2022, with the low at $57000.0 in Q4 2023.
- Historically, Long-Term Investments has averaged $109750.0 across 4 years, with a median of $97000.0 in 2024.
- Annual changes were most pronounced in 2023 — Long-Term Investments sank 69.68% — and 2024, when it soared 107.02%.
- CollPlant Biotechnologies' Long-Term Investments stood at $188000.0 in 2022, then slumped by 69.68% to $57000.0 in 2023, then surged by 107.02% to $118000.0 in 2024, then sank by 35.59% to $76000.0 in 2025.
- The last three Long-Term Investments figures came in at $76000.0 (Q4 2025), $118000.0 (Q4 2024), and $57000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 188,000.00 |